QUANTASS ApS

  • Inactive

  • Registration 35244492
  • APS
  • Established 8 May, 2013
  • Dissolved 14 December, 2020

Company information
No advertising

Legal form
Anpartsselskab (APS)
Status

Inactive

 Established 8 May, 2013 Dissolved 14 December, 2020
Address
Ravnebakkevej 6
C/O Kronborggård
3490 Kvistgård
Denmark
Phone: 28447567
Registration number
Registration 35244492

Relations

Past relations
Ultimate beneficial owners (UBOs)
  • Jeppe Øvli Øvlesen
    2013-05-08 – 2020-12-14 50% ownership (2013-05-08 – 2020-12-14 ) 50% voting rights (2013-05-08 – 2020-12-14 )
  • Ghita Vinter Øvlesen
    2013-05-08 – 2020-12-14 50% ownership (2013-05-08 – 2020-12-14 ) 50% voting rights (2013-05-08 – 2020-12-14 )
Legal owners
  • Jeppe Øvli Øvlesen
    2013-05-08 – 2020-12-14 50% ownership (2013-05-08 – 2020-12-14 ) 50% voting rights (2013-05-08 – 2020-12-14 )
  • Ghita Vinter Øvlesen
    2013-05-08 – 2020-12-14 50% ownership (2013-05-08 – 2020-12-14 ) 50% voting rights (2013-05-08 – 2020-12-14 )
Subsidiaries
  • ResoTher Pharma A/S 50% ownership (2016-07-04 – 2017-04-18 ) 33.33% ownership (2017-04-19 – 2017-11-22 ) 25% ownership (2017-11-23 – 2019-10-27 ) 20% ownership (2019-10-28 – 2020-01-30 ) 15% ownership (2020-01-31 – 2020-12-13 ) 50% voting rights (2016-07-04 – 2017-04-18 ) 33.33% voting rights (2017-04-19 – 2017-11-22 ) 25% voting rights (2017-11-23 – 2019-10-27 ) 20% voting rights (2019-10-28 – 2020-01-30 ) 15% voting rights (2020-01-31 – 2020-12-13 )
  • ResoTher Pharma A/S 50% ownership (2016-07-04 – 2017-04-18 ) 33.33% ownership (2017-04-19 – 2017-11-22 ) 25% ownership (2017-11-23 – 2019-10-27 ) 20% ownership (2019-10-28 – 2020-01-30 ) 15% ownership (2020-01-31 – 2020-12-13 ) 50% voting rights (2016-07-04 – 2017-04-18 ) 33.33% voting rights (2017-04-19 – 2017-11-22 ) 25% voting rights (2017-11-23 – 2019-10-27 ) 20% voting rights (2019-10-28 – 2020-01-30 ) 15% voting rights (2020-01-31 – 2020-12-13 )
  • ResoTher Pharma A/S 50% ownership (2016-07-04 – 2017-04-18 ) 33.33% ownership (2017-04-19 – 2017-11-22 ) 25% ownership (2017-11-23 – 2019-10-27 ) 20% ownership (2019-10-28 – 2020-01-30 ) 15% ownership (2020-01-31 – 2020-12-13 ) 50% voting rights (2016-07-04 – 2017-04-18 ) 33.33% voting rights (2017-04-19 – 2017-11-22 ) 25% voting rights (2017-11-23 – 2019-10-27 ) 20% voting rights (2019-10-28 – 2020-01-30 ) 15% voting rights (2020-01-31 – 2020-12-13 )
  • ResoTher Pharma A/S 50% ownership (2016-07-04 – 2017-04-18 ) 33.33% ownership (2017-04-19 – 2017-11-22 ) 25% ownership (2017-11-23 – 2019-10-27 ) 20% ownership (2019-10-28 – 2020-01-30 ) 15% ownership (2020-01-31 – 2020-12-13 ) 50% voting rights (2016-07-04 – 2017-04-18 ) 33.33% voting rights (2017-04-19 – 2017-11-22 ) 25% voting rights (2017-11-23 – 2019-10-27 ) 20% voting rights (2019-10-28 – 2020-01-30 ) 15% voting rights (2020-01-31 – 2020-12-13 )
  • ResoTher Pharma A/S 50% ownership (2016-07-04 – 2017-04-18 ) 33.33% ownership (2017-04-19 – 2017-11-22 ) 25% ownership (2017-11-23 – 2019-10-27 ) 20% ownership (2019-10-28 – 2020-01-30 ) 15% ownership (2020-01-31 – 2020-12-13 ) 50% voting rights (2016-07-04 – 2017-04-18 ) 33.33% voting rights (2017-04-19 – 2017-11-22 ) 25% voting rights (2017-11-23 – 2019-10-27 ) 20% voting rights (2019-10-28 – 2020-01-30 ) 15% voting rights (2020-01-31 – 2020-12-13 )
  • Falcon Invest C25 Momentum A/S 5% ownership (2017-05-16 – 2017-12-20 ) 5% voting rights (2017-05-16 – 2017-12-20 )
  • MEDCONNECT A/S 15% ownership (2017-01-01 – 2017-02-24 ) 15% voting rights (2017-01-01 – 2017-02-24 )

Financial reports

Revenue
Profit/loss
'000 09-2014 12-2015 12-2016 12-2017
Currency DKK DKK DKK DKK
Revenue 0 0 0 0
Raw materials and consumables used 0 0 0 0
Other external expenses 0 0 0 0
Gross profit loss -37 0 -21 37
Employee benefits expense 0 0 0 0
Wages and salaries 0 0 0 0
Depreciation amortisation expense and impairment losses of prop 0 0 0 0
Profit loss from ordinary operating activities 0 -16 0 0
Profit loss from ordinary activities before tax -37 -16 8,823 5,134
Other finance expenses 0 0 5 0
Tax expense 0 0 0 38
Profit loss -37 -16 8,823 5,096